Clinical Characteristics and Risk Factors for Pleural Effusion in Patients with Multiple Myeloma

References

• Light RW. Pleural effusions. Med Clin North Am. 2011;95(6):1055–1070.
   PubMed Web of Science ®Google Scholar
• Light RW. Clinical practice. Pleural effusion. N Engl J Med. 2002;346(25):1971–1977.
   PubMed Web of Science ®Google Scholar
• Sahn SA, Heffner JE. Pleural fluid analysis. In: Light RW, Lee YCG, editors. Textbook of Pleural Diseases. 2nd. London, UK: Arnold Press; 2008:209–216
   Google Scholar
• BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii4–ii17.
   PubMedGoogle Scholar
• Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007;2(8):706–714.
   PubMed Web of Science ®Google Scholar
• Ryu JS, Azra M, Lee SK, et al. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer. J Clin Oncol. 2014;32(9):960–967.
   PubMed Web of Science ®Google Scholar
• Nakaya A, Fujita S, Satake A, et al. Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia. Hematol Rep. 2018;10(3):7474.
   PubMed Web of Science ®Google Scholar
• Porkka K, Khoury HJ, Paquette RL, et al. Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion. Cancer. 2010;116(2):377–386.
   PubMed Web of Science ®Google Scholar
• Röllig C, Knop S, Bornhäuser M, et al. Multiple myeloma. Lancet. 2015;385(9983):2197–2208.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A, et al. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
   PubMed Web of Science ®Google Scholar
• Chen JH, Chung CH, Wang YC, et al. Prevalence and mortality-related factors of multiple myeloma in Taiwan. PLoS One. 2016;11(12):e0167227.
   PubMed Web of Science ®Google Scholar
• Park HJ, Park EH, Jung KW, et al. Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008. Korean J Hematol. 2012;47(1):28–38.
   PubMedGoogle Scholar
• Lu J, Lu J, Chen W, et al. The Chinese medical doctor association hematology branch. Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: results of a multicenter analysis. Blood Cancer J. 2014;4:e239. doi:10.1038/bcj.2014.55
   PubMed Web of Science ®Google Scholar
• Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111:2962–2972.
   PubMed Web of Science ®Google Scholar
• Wang Z, Xia G, Lan L, et al. Pleural effusion in multiple myeloma. Intern Med. 2016;55(4):339–345.
   PubMed Web of Science ®Google Scholar
• Byun JM, Kim KH, Choi IS, et al. Pleural effusion in multiple myeloma: characteristics and practice patterns. Acta Haematol. 2017;138(2):69–76.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91(7):719–734.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV. Myeloma today: disease definitions and treatment advances. Am J Hematol. 2016;91(1):90–100.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23:3–9.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Harousseau JL, Durie B, et al. Consensus recommendations for the uniform reporting of clinical trials: report of the International myeloma workshop consensus panel 1. Blood. 2011;117:4691–4695.
   PubMed Web of Science ®Google Scholar
• Moy MP, Levsky JM, Berko NS, et al. A new, simple method for estimating pleural effusion size on CT scans. Chest. 2013;143(4):1054–1059.
   PubMed Web of Science ®Google Scholar
• Juan NR. Pleural effusion in multiple myeloma. Chest. 1994;105:622–624.
   PubMed Web of Science ®Google Scholar
• Kamble R, Wilson CS, Fassas A, et al. Malignant pleural effusion of multiple myeloma: prognostic factors and outcome. Leuk Lymphoma. 2005;46(8):1137–1142.
   PubMed Web of Science ®Google Scholar
• Zhang LL, Li YY, Hu CP, et al. Myelomatous pleural effusion as an initial sign of multiple myeloma - a case report and review of literature. J Thorac Dis. 2014;6(7):E152–E159.
   PubMed Web of Science ®Google Scholar
• Saidane O, Slouma M, Haouet S, et al. Cutaneous and pleural involvement in a patient with multiple myeloma. BMJ Case Rep. 2015;201.
   Google Scholar
• Rajkumar SV. Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management. Am J Hematol. 2018;93(8):981–1114.
   PubMed Web of Science ®Google Scholar
• Gerecke C, Fuhrmann S, Strifler S, et al. The diagnosis and treatment of multiple myeloma. Dtsch Arztebl Int. 2016;113(27–28):470–476.
   PubMed Web of Science ®Google Scholar
• Chetan BP, Neeraj G, Rakesh CG, et al. Varna Indushekar Myelomatous pleural effusion-thoracoscopic evaluation of a rare entity. Lung India. 2015;32(5):505–507.
   PubMedGoogle Scholar
• George S, Ravindran M, Anandan PT, et al. Primary systemic amyloidosis: a rare cause for pleural effusion. Respir Med Case Rep. 2014;13:39–42.
   PubMedGoogle Scholar
• Kistler K, Rajangam K, Faich G. Cardiac event rates in patients with newly diagnosed and relapsed multiple myeloma in US clinical practice. Blood. 2012;120:2916.
   Web of Science ®Google Scholar
• Dipenkumar M, Hyejeong J, Seongho K, et al. Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2016;91(9):E341–E347.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kim SJ, Min K, et al. Multiple myeloma with myelomatous pleural effusion: a case report and review of the literature. Acta Haematol. 2008;120(2):108–111.
   PubMed Web of Science ®Google Scholar
• Arora P, Gupta SK, Mallik N, et al. Flow cytometry in diagnosis of myelomatous pleural effusion: a case report. Indian J Hematol Blood Transfus. 2016;32(Suppl 1):138–342.
   PubMed Web of Science ®Google Scholar
• Mangla A, Agarwal N, Kim GJ, et al. Primary malignant myelomatous pleural effusion. Clin Case Rep. 2016;4(8):803–806.
   PubMedGoogle Scholar
• Vakil E, Jimenez CA, Faiz SA, et al. Pleural effusions in hematologic malignancies and their management with indwelling pleural catheters. Curr Opin Pulm Med. 2018;24(4):384–391.
   PubMed Web of Science ®Google Scholar